This article is
- freely available
A Review of Topical Diclofenac Use in Musculoskeletal Disease
Division of Rheumatology, University of Saskatchewan, Royal University Hospital, Saskatoon, Saskatchewan S7N 0W8, Canada
* Author to whom correspondence should be addressed.
Received: 22 April 2010; in revised form: 28 May 2010 / Accepted: 8 June 2010 / Published: 11 June 2010
Abstract: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the treatment of musculoskeletal disorders. Osteoarthritis is the most common form of arthritis in humans and its prevalence rises with age. Oral NSAIDs have potential associated toxicities that must be monitored for and can limit the use of these drugs in certain populations including people of older age. Topical NSAIDs are now being recognized as an option for the treatment strategy of osteoarthritis. We review the efficacy and safety of one of the most common topical NSAIDS, topical diclofenac, for the treatment of osteoarthritis.
Keywords: NSAIDs; musculoskeletal; osteoarthritis; diclofenac
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Nair, B.; Taylor-Gjevre, R. A Review of Topical Diclofenac Use in Musculoskeletal Disease. Pharmaceuticals 2010, 3, 1892-1908.
Nair B, Taylor-Gjevre R. A Review of Topical Diclofenac Use in Musculoskeletal Disease. Pharmaceuticals. 2010; 3(6):1892-1908.
Nair, Bindu; Taylor-Gjevre, Regina. 2010. "A Review of Topical Diclofenac Use in Musculoskeletal Disease." Pharmaceuticals 3, no. 6: 1892-1908.